title: Inflammatory bowel disease and pregnancy: an update.
abstract: Women with inflammatory bowel disease have similar rates of conception to the general population unless they have had pelvic surgery. Once pregnant, regardless of disease activity, they have an increased risk of adverse pregnancy outcome and should be followed as high-risk obstetric patients. Most medications are compatible with pregnancy and lactation, as described in this article. Ideally, women should discuss their plans for pregnancy with their physician prior to conception so that risks and benefits can be reviewed, medications adjusted and healthcare maintenance updated. Once pregnant, a multidisciplinary team of gastroenterologists, obstetricians and pediatricians should help to ensure the best care for the mother and child.
authors.affiliation: University of Rochester Medical Center, Rochester, NY, USA.
authors.forename: Lola Y
authors.initials: LY
authors.lastname: Kwan
authors.forename: Uma
authors.initials: U
authors.lastname: Mahadevan
mesh_terms: D001942:Breast Feeding; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy / Q000276:immunology*; D007774:Lactation / Q000276:immunology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000276:immunology*; D011256:Pregnancy Outcome; D018570:Risk Assessment